Applications Published 11 October 2000
Published: 25-May-2001
aThe following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
aThe following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
New compounds which are P2-purinoceptor 7-transmembrane (TM) G-protein coupled receptor antagonists
AstraZeneca 1042320*Substituted thiazolidinedione derivatives, process for its preparation and its pharmaceutical use
SmithKline Beecham 1042321*KV2.1 antagonists
Glaxo Group1042322*Novel camptothecin tetracyclic analogues, preparation, methods, applications as medicines and pharmaceutical compsns containing them
Societe de Conseils de Recherches et d'Applications Scientifiques 1042323*Heterocyclic compounds for inhibition of gastric acid secretions, processes for their preparation and pharmaceutical compsns containing them
AstraZeneca 1042324*Nitrogen-containing heterocyclic compounds, their production and use
Takeda Chemical Industry 1042325*Novel acronycine derivatives, preparation method and pharmaceutical compsns
Adir et Compagnie 1042326*A process for the reduction of orixanyl epithilones to olefinic epothilones
Bristol-Myers Squibb 1042327*Sarcodictin and eleutherobin derivatives useful for stabilising microtubules
Novartis 1042328*Novel farnesyl transferase inhibitors, preparation, pharmaceutical compsns containing them and use for preparing medicines
Aventis Pharma 1042329*Product containing magnesium, halogen and alkoxy
Borealis Technology 1042330*Soluble magnesium dihalide complex, preparation and use
Borealis Technology 1042331*Beta-lacatmase and DD-peptidase inhibitors
Methylgene; Wesleyan University 1042334*Vitamin D derivatives with phosphorus atoms in the side chains
Schering 104235*Pi-complex compounds
Bayer 1042336*Oligonucleotide synthesis using high boiling point solvents
Protogene Laboratories 1042337*Process for preparing pale-coloured and transparent alkyl glycosides
LG Chemical 1042338*Carbohydrates, useful in solid delivery systems
Quadrant Holdings Cambridge 1042339*6-O-alkyl erythromycin B oxime
Abbott Laboratories 1042340*Nucleoside analogue compsns and uses thereof
Protarga 1042341*53 secreted human proteins
Human Genome Sciences 1042342*Vegi, an inhibitor of angiogenesis and tumour growth
Human Genome Sciences; Georgetown University Medical Centre 1042343*Conductive metal-containing nucleic acids
University of Saskatchewan 1042344*Compounds for mass spectrometry comprising nucleic aci dbases and aryl ether mass markers
Brax Group 1032345*86 human secreted proteins
Human Genome Sciences 1042346*DNA pharmaceutical formulations comprising citrate of triethanolamine and combinations thereof
Merck & Co 1042347*Platelet derived growth factor (PDGF) nucleic acid ligand complexes
NeXstar Pharmaceuticals 1042348*Using polyamide nucleic acid oligomers to engender a biological response
Mayo Foundation for Medical Education and Research 1042349*Inducible phosphofructokinase and the Warburg effect
The Picower Institute for Medical Research 1042350*Androgenic steroid compounds and a method of making and using the same
Research Triangle Institute 1042352*Estrone sulfamate inhibitors of estrone sulfatase, and associated compsns and methods of use
SRI International 1042354*11beta-halogen-7alpha-substituted estratrienes, method for producing pharmaceutical preparations containing said 11beta-halogen-7alpha-substituted estratrienes and use of the same for producing medicaments
Schering 1042355*Intermediates and process for the synthesis of 17-unsubstituted 16-beta-aryloxy 4-azasteroids
Merck 1042356*Process for the preparation of solid polymer composites
Avecia 1042357*Free solution ligand interaction molecular separation method
Genentech 1042358*Kappa receptor opioid peptides
Ferring 1042359*Essential bacterial genes and their use
Millennium Pharmaceuticals 1042361*Human regulatory proteins
Incyte Pharmaceuticals 1042362*Novel anti-HIV immunogens (toxoids), preparation methods and use for preventing and treating AIDS
Neovacs 1042363*Antivirally active oligopeptide isolated from royal jelly
GSF – Forschungszentrum fur Umwelt un Gesundheit 1042364*Compounds and methods for modulating occludin related tissue permeability
Adherex Technologies 1042365*Peptide epitopes recognised by antifilaggrin autoantibodies in serum from rheumatoid arthritis patients
Biomerieux 1042366*Antibodies against phosphorylated VASP (vasodilator-stimulated phosphoprotein), hybridoma cells for their prearation, and their use
Aventis Pharma Deutschland 1042368*Medicinal compsns for percutaneous administration
Daiichi Pharmaceutical 1043020Type 2 helper cell-selective immune response suppressors
Japan Enrgy Corp 1043021Sodium ion absorption inhibitors, sodium ion excretion accelerators, and preventative and therapeutic agents for diseases resulting from the excess intake of common salt
Otsuka Pharmaceutical Factory 1043022Viscous compsns containinh carbon dioxide
Medion Research Laboratories 1043023Chromic myeloid leukaemia (cml) therapy
Schering 1043024Renal cell carcinoma treatment
Schering 1043025Melanoma therapy
Scheing 1043026Treatment of multiple sclerosis with a combination of interferon and growth hormone
Applied Research Systems 1043027Method for preventing/remedying mastitis
Kyowa Hakko Kogyo 1043028Campylobacter vaccine
Akzo Nobel 1043029Sustained release medical compsns
Yamanouchi Pharmaceuticals; Toray Industries 1043030Sustained release medicinal compsns
Yamanouchi Pharmaceuticals 10430313-amino-3-arylpropan-1-ol derivatives, their preparation and use
Grunenthal 1043306Phenylaminoalkylcarboxylic acid derivatives and medicinal compsns containing the same
Kissei Pharmaceutical 1043308Process for synthesising para- and/or meta-substituted cyanophenylalanine
LG Chemical 1043309Biphenylamidine derivatives
Teijin 1043310Biphenylamidine derivatives
Teijin 1043311Heterocyclic compounds having NOS inhibitory activities
Chugai 1043312Novel dihydropyridine derivative
Ajinomoto 1043314Steroid receptor modulator compounds and methods
Ligand Pharmaceuticals 1043315Nitroimidazole derivatives as sensitivity enhancers for chemotherapy and radiotherapy
S&H Pharm Technology 1043316Novel pyridazine derivatives and drugs containing the same as the active ingredient
Kowa 1043317Salts of 5,5'-arylidenbisbarbituric and 5,5'-arylidenebis(2-thiobarbituric)acids and 5,5'-arylidenebis(2-thiobarbituric)acids having an antibacterial, anti-chlamydial, antiviral and immuno-modulating activity
Tets, Viktor Veniaminovich 1043318 Novel alkylamino derivatives
Mitsubishi Chemical 1043319 New process for producing aminopiperazine derivatives
Fujisawa Pharmaceutical 1043320Process for the preparation of tetrahydropyran derivatives
Nisshin Flour Milling1-43321Vitamin E derivatives
Senju Pharmaceutical 1043322Triketone derivatives
Idemitsu Kosan 1043323Purine derivatives and medicine containing the same as the active ingredient
Mitusbishi Chemical 1043324Steroid receptor modulator compounds and methods
Ligand Pharmaceuticals 1043325Prosphonocephem derivatives, process for the preparation of the same, and use thereof
Takeda Chemical Industries 1043327Novel physiologically active substance sulphostin, process for producing the same, and use thereof
Zaidan Hojin Biseibutsu 1043328Bone-resorptive cytokine inhibitor containing dienogest as the active ingredient
Mochida Pharmaceutical 1043331Dipeptides comprising cyclopentan-beta-amino acids
Bayer 1043332Novel polypeptides, CDNAs encoding the same and utilisation thereof
Ono Pharmaceuticals 1043333Monoclonal antibody against connective tissue growth factor and medicinal uses thereof
Japan Tobaco 1043335
